- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/68 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Patent holdings for IPC class C07D 333/68
Total number of patents in this class: 106
10-year publication summary
|
6
|
3
|
11
|
9
|
5
|
8
|
8
|
9
|
7
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Astellas Pharma Inc. | 1041 |
6 |
| Enyo Pharma | 53 |
5 |
| Nflection Therapeutics, Inc. | 37 |
4 |
| The Royal Institution for The Advancement of Learning / McGill University | 714 |
4 |
| Neurasic Therapeutics Inc. | 6 |
4 |
| Katholieke Universiteit Leuven | 1274 |
3 |
| King Faisal University | 931 |
3 |
| Sanofi | 4297 |
3 |
| Bristol-myers Squibb Company | 4721 |
2 |
| The Regents of the University of California | 20690 |
2 |
| Takeda Pharmaceutical Company Limited | 2714 |
2 |
| Activesite Pharmaceuticals, Inc. | 18 |
2 |
| Chiesi Farmaceutici S.p.A. | 960 |
2 |
| Institut Pasteur Korea | 50 |
2 |
| Kyowa Hakko Kirin Co., Ltd. | 270 |
2 |
| National University Corporation Tokyo Medical and Dental University | 493 |
2 |
| Promega Corporation | 587 |
2 |
| H. Lundbeck A/S | 1231 |
2 |
| Janssen Biopharma, Inc. | 32 |
2 |
| Shanghai Yuyao Biotech Ltd. | 12 |
2 |
| Other owners | 50 |